Keane Capital Partners adds Cooper Companies Inc (COO) to its portfolio

Cooper Companies Inc (COO) : Keane Capital Partners added new position in Cooper Companies Inc during the most recent quarter end. The investment management firm now holds 22,000 shares of Cooper Companies Inc which is valued at $3,977,820 , the company said in a statement filed on Aug 15, 2016 with the SEC.Cooper Companies Inc makes up approximately 8.66% of Keane Capital Partners’s portfolio.

Other Hedge Funds, Including , Everpoint Asset Management added COO to its portfolio by purchasing 150,000 company shares during the most recent quarter which is valued at $27,121,500. Cooper Companies Inc makes up approx 0.71% of Everpoint Asset Management’s portfolio.Plante Moran Financial Advisors reduced its stake in COO by selling 4 shares or 1.24% in the most recent quarter. The Hedge Fund company now holds 318 shares of COO which is valued at $57,653. Cooper Companies Inc makes up approx 0.04% of Plante Moran Financial Advisors’s portfolio.Diam Ltd. reduced its stake in COO by selling 461 shares or 3.41% in the most recent quarter. The Hedge Fund company now holds 13,053 shares of COO which is valued at $2,366,509. Cooper Companies Inc makes up approx 0.03% of Diam Ltd.’s portfolio.Zurcher Kantonalbank (zurich Cantonalbank) reduced its stake in COO by selling 177 shares or 4.48% in the most recent quarter. The Hedge Fund company now holds 3,774 shares of COO which is valued at $684,226. Cooper Companies Inc makes up approx 0.01% of Zurcher Kantonalbank (zurich Cantonalbank)’s portfolio.Kalmar Investments Inc De reduced its stake in COO by selling 81,290 shares or 25.56% in the most recent quarter. The Hedge Fund company now holds 236,731 shares of COO which is valued at $43,196,306. Cooper Companies Inc makes up approx 1.84% of Kalmar Investments Inc De’s portfolio.

Cooper Companies Inc closed down -0.55 points or -0.30% at $185.37 with 3,96,014 shares getting traded on Thursday. Post opening the session at $185.39, the shares hit an intraday low of $184.37 and an intraday high of $186.65 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Cooper Companies Inc reported $2.30 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Sep 1, 2016. Analyst had a consensus of $2.29. The company had revenue of $514.70 million for the quarter, compared to analysts expectations of $512.63 million. The company’s revenue was up 11.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.97 EPS.

Many Wall Street Analysts have commented on Cooper Companies Inc. Company shares were Reiterated by BMO Capital Markets on Sep 2, 2016 to “Outperform”, Firm has raised the Price Target to $ 206 from a previous price target of $199 .Company shares were Reiterated by Stifel on Aug 31, 2016 to “Buy”, Firm has raised the Price Target to $ 215 from a previous price target of $195 .Company shares were Reiterated by Stifel on Jun 30, 2016 to “Buy”, Firm has raised the Price Target to $ 195 from a previous price target of $180 .

The Cooper Companies Inc. (Cooper) is a global medical device company. The Company operates through two business units CooperVision Inc. (CVI) and CooperSurgical Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women’s health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital Office and Fertility Clinic. CooperVision develops manufactures and markets a range of monthly two-week and single-use contact lenses featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism presbyopia and ocular dryness and provides innovative contact lens solutions. The CooperVision Company’s brands include Biofinity Avaira and MyDay and CooperSurgical Company’s brands include Advincula Arch SeeClear and Mobius.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *